OTS Lifetime Achievement Award Grant
Oligonucleotide Therapeutics Society
Funding Amount
US $2,500
Deadline
Deadline not published
Grant Type
Foundation
Can we apply?
Check your organization against each line. Taken from the listing; confirm with the funder's guidelines.
Other requirements
- Applicants falling into the categories of emeritus, academic professional (minimally at the rank of assistant professor), or industry professional can be nominated.
- Nominees and nominators for this award do not need to be OTS members for a nominee to be considered
Overview
The OTS Lifetime Achievement Award honors individuals who have significantly advanced the field of oligonucleotide therapeutics. Established by the Oligonucleotide Therapeutics Society, this award recognizes those who have made impactful contributions through research, mentorship, or leadership in the community. Recipients receive a $2,500 award, complimentary registration to the OTS Annual Meeting, and a keynote speaking opportunity, celebrating their lasting commitment to advancing therapeutic applications in oligonucleotide medicine.
About the Oligonucleotide Therapeutics Society (OTS)
The idea for the OTS was conceived in 2001 in a small secluded castle in Tuscany, Italy, by an international group of renowned oligonucleotide scientists. The idea of the founders was to bring together the expertise from different angles of oligonucleotide research to create synergies and to bring the field of oligonucleotides to its full therapeutic potential. A new era of oligonucleotide drugs was envisioned that would change the landscape of therapeutic modalities,very much like the impact that antibodies had on human therapeutics over the last decade.
The highly regarded annual OTS meeting draws experts from all over the world for cross-disciplinary exchange spanning expertise in chemistry and delivery, to biology, immunology and clinical medicine.
The OTS Lifetime Achievement Award recognizes an individual who has demonstrated a lasting commitment to the field of oligonucleotide therapeutics through outstanding contributions to education, research, and therapeutic application and are an outstanding example to young or new members of the field. Such individuals may have made this contribution through one, or many, of the following descriptions:
An individual who has made a significant scientific contribution to the field of oligonucleotide medicine, over decades, by means of multiple high impact publications, leadership in the oligonucleotide community, and mentorship to traineesAn individual who has made an exceptional scientific contribution to the field of oligonucleotide medicine through the publication of one or more revolutionary papers which have made an immediate and significant contribution to the field of oligonucleotide medicineAn individual who has played a critical role, over decades, guiding decisions at companies and/or in academia and who might not be identified with any one scientific discoveryAn individual who has played a critical role, over decades, in the leadership and/or mentorship or a prolific group of scientists/trainees
Recipient receives:
$2,500 USD awardComplimentary registration to the OTS Annual MeetingFormal presentation of the award at the OTS Annual MeetingKeynote speaking slot at the OTS Annual Meeting
Eligibility
Applicants falling into the categories of emeritus, academic professional (minimally at the rank of assistant professor), or industry professional can be nominated.Nominees and nominators for this award do not need to be OTS members for a nominee to be considered
Focus Areas & Funding Uses
Fields of Work
- Science research
Categories
Browse similar grants by category
Related Grants
Open grants from this funder and similar programs
Poster Awards Grant
Oligonucleotide Therapeutics Society
Amount
US $250
Deadline
Deadline not published
Oligonucleotide Therapeutic Society: Travel Grants
Oligonucleotide Therapeutics Society
Amount
US $1,000 - US $1,500
Deadline
Deadline not published
Parkinson's Disease Therapeutics Pipeline Grant Program
The Michael J Fox Foundation for Parkinson's Research
Amount
US $250,000 - US $2,000,000
Deadline
October 30, 2026
Listed date — confirm with the funder
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
National Institutes of Health
Amount
$2,000,000 total
Deadline
October 30, 2026
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
National Institutes of Health
Amount
$3 – $500K
Deadline
October 30, 2026
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
National Institutes of Health
Amount
$3,000,000 total
Deadline
October 30, 2026
Ready to apply for OTS Lifetime Achievement Award Grant?
Grantable helps you assess fit, draft narratives, and track deadlines — so you can submit stronger applications, faster.
You found OTS Lifetime Achievement Award Grant. Now let's win it.